CRISPR Use Could Lead to “Organic” Gene Therapies for Blood Disorders – Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News |
CRISPR Use Could Lead to "Organic" Gene Therapies for Blood Disorders
Genetic Engineering & Biotechnology News The team, led by University of New South Wales (UNSW) professor Merlin Crossley, Ph.D., has identified the gene-control mechanism that allows some individuals with these blood disorders to keep producing a fetal form of human hemoglobin, which … Solution to 50-year-old mystery could lead to gene therapy for common blood disorders |
